300 related articles for article (PubMed ID: 17085380)
1. Effect of different preparations of hormone therapy on sexual dysfunction in naturally postmenopausal women.
Osmanağaoğlu MA; Atasaral T; Baltaci D; Bozkaya H
Climacteric; 2006 Dec; 9(6):464-72. PubMed ID: 17085380
[TBL] [Abstract][Full Text] [Related]
2. Quality of life and sexuality changes in postmenopausal women receiving tibolone therapy.
Wu MH; Pan HA; Wang ST; Hsu CC; Chang FM; Huang KE
Climacteric; 2001 Dec; 4(4):314-9. PubMed ID: 11770188
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women.
Ziaei S; Moghasemi M; Faghihzadeh S
Climacteric; 2010 Apr; 13(2):147-56. PubMed ID: 19731119
[TBL] [Abstract][Full Text] [Related]
4. Clitoral circulation in postmenopausal women with sexual dysfunction: a pilot randomized study with hormone therapy.
Nappi RE; Ferdeghini F; Sampaolo P; Vaccaro P; De Leonardis C; Albani F; Salonia A; Polatti F
Maturitas; 2006 Oct; 55(3):288-95. PubMed ID: 16730929
[TBL] [Abstract][Full Text] [Related]
5. Effect on sexual life--a comparison between tibolone and continuous combined conjugated equine estrogens and medroxyprogesterone acetate.
Uygur D; Yeşildaglar N; Erkaya S
Gynecol Endocrinol; 2005 Apr; 20(4):209-12. PubMed ID: 16019363
[TBL] [Abstract][Full Text] [Related]
6. Sexual dysfunction in the peri- and postmenopause. Status of incidence, pharmacological treatment and possible risks. A secondary publication.
Gregersen N; Jensen PT; Giraldi AE
Dan Med Bull; 2006 Aug; 53(3):349-53. PubMed ID: 17092454
[TBL] [Abstract][Full Text] [Related]
7. Effects of tibolone and raloxifene on health-related quality of life and sexual function.
Nijland EA; Weijmar Schultz WC; Davis SR
Maturitas; 2007 Oct; 58(2):164-73. PubMed ID: 17870260
[TBL] [Abstract][Full Text] [Related]
8. Effects of a continuous-combined regimen of low-dose hormone therapy (oestradiol and norethindrone acetate) and tibolone on the quality of life in symptomatic postmenopausal women: a double-blind, randomised study.
Polisseni AF; Andrade AT; Ribeiro LC; Castro IQ; Brandão M; Polisseni F; Guerra Mde O
Maturitas; 2013 Feb; 74(2):172-8. PubMed ID: 23201326
[TBL] [Abstract][Full Text] [Related]
9. Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial.
Nijland EA; Weijmar Schultz WC; Nathorst-Boös J; Helmond FA; Van Lunsen RH; Palacios S; Norman RJ; Mulder RJ; Davis SR;
J Sex Med; 2008 Mar; 5(3):646-56. PubMed ID: 18304284
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of hormone therapy regimens, oral and vaginal estradiol, estradiol + drospirenone and tibolone, on sexual function in healthy postmenopausal women.
Cayan F; Dilek U; Pata O; Dilek S
J Sex Med; 2008 Jan; 5(1):132-8. PubMed ID: 17961145
[TBL] [Abstract][Full Text] [Related]
11. Effect of tibolone on sexual function in late postmenopausal women.
Kamenov ZA; Todorova MK; Christov VG
Folia Med (Plovdiv); 2007; 49(1-2):41-8. PubMed ID: 18018469
[TBL] [Abstract][Full Text] [Related]
12. [Aging and sexuality in women].
Nappi RE; Albani F; Valentino V; Polatti F; Chiovato L; Genazzani AR
Minerva Ginecol; 2007 Jun; 59(3):287-98. PubMed ID: 17576405
[TBL] [Abstract][Full Text] [Related]
13. Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women.
Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Berger L; Gilbert L; Martel C; Balser J
Menopause; 2009; 16(5):923-31. PubMed ID: 19424093
[TBL] [Abstract][Full Text] [Related]
14. Sleep, vigilance and cognition in postmenopausal women: placebo-controlled studies with 2 mg estradiol valerate, with and without 3 mg dienogest.
Saletu B
Climacteric; 2003 Aug; 6 Suppl 2():37-45. PubMed ID: 14669843
[TBL] [Abstract][Full Text] [Related]
15. Effect of long-term continuous combined hormone replacement therapy with estradiol valerate and either dienogest or norethisterone acetate on mammographic density in postmenopausal women.
Georgiev DB; Manassiev NA
Medscape Womens Health; 2002; 7(4):1. PubMed ID: 12466733
[TBL] [Abstract][Full Text] [Related]
16. [Sexual dysfunction in the menopause. Incidence, pharmacological treatment and side effects].
Gregersen N; Hilmand CB; Jensen PT; Giraldi AG
Ugeskr Laeger; 2006 Feb; 168(6):559-63. PubMed ID: 16476214
[TBL] [Abstract][Full Text] [Related]
17. Testosterone treatment of HSDD in naturally menopausal women: the ADORE study.
Panay N; Al-Azzawi F; Bouchard C; Davis SR; Eden J; Lodhi I; Rees M; Rodenberg CA; Rymer J; Schwenkhagen A; Sturdee DW
Climacteric; 2010 Apr; 13(2):121-31. PubMed ID: 20166859
[TBL] [Abstract][Full Text] [Related]
18. Effect of 1-year, low-dose DHEA therapy on climacteric symptoms and female sexuality.
Genazzani AR; Stomati M; Valentino V; Pluchino N; Pot E; Casarosa E; Merlini S; Giannini A; Luisi M
Climacteric; 2011 Dec; 14(6):661-8. PubMed ID: 21942655
[TBL] [Abstract][Full Text] [Related]
19. Sexual psychophysiology and effects of sildenafil citrate in oestrogenised women with acquired genital arousal disorder and impaired orgasm: a randomised controlled trial.
Basson R; Brotto LA
BJOG; 2003 Nov; 110(11):1014-24. PubMed ID: 14592587
[TBL] [Abstract][Full Text] [Related]
20. Improved bleeding profile and tolerability of tibolone versus transdermal E2/NETA treatment in postmenopausal women with female sexual dysfunction.
Nijland EA; Nathorst-Böös J; Palacios S; van de Weijer PW; Davis S; Stathopoulos VM; Birkhaeuser MH; von Mauw E; Mulder RJ; Schultz WC;
Climacteric; 2009 Apr; 12(2):114-21. PubMed ID: 19177255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]